LMNA and metabolic syndrome: Particularly, in some very rare cases, mutations have been associated with an attenuated phenotype of lipodystrophy without lipoatrophy and corresponding to severe metabolic syndrome (MS), a condition that shares common features with FPLD2, such as dyslipidemia, insulin resistance and central adiposity [10,13,14].